Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:781-788, doi:10.1016/j.jacc.2005.09.059 (Published online 27 January 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.09.059v1
j.jacc.2005.09.059v2
47/4/781    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navare, S. M.
Right arrow Articles by Heller, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navare, S. M.
Right arrow Articles by Heller, G. V.

CLINICAL RESEARCH: CARDIAC IMAGING

Risk Stratification With Electrocardiographic-Gated Dobutamine Stress Technetium-99m Sestamibi Single-Photon Emission Tomographic Imaging

Value of Heart Rate Response and Assessment of Left Ventricular Function

Sachin M. Navare, MD*,{dagger}, Deborah Katten, RN, MPH*, Lynne L. Johnson, MD{ddagger},§, Jeffery F. Mather, MS*, Michael S. Fowler, MD*,{dagger}, Alan W. Ahlberg, MA*, Nicholas Miele, BS{ddagger},§ and Gary V. Heller, MD, PhD*,{dagger},*

* Nuclear Cardiology Laboratory of the Henry Low Heart Center, Hartford Hospital, Hartford, Connecticut
{dagger} University of Connecticut School of Medicine, Farmington, Connecticut
{ddagger} Nuclear Cardiology Laboratory, Cardiology Division of the Rhode Island Hospital, Providence, Rhode Island
§ Brown University School of Medicine, Providence, Rhode Island.

Manuscript received March 10, 2005; revised manuscript received August 11, 2005, accepted September 19, 2005.

* Address for correspondence: Dr. Gary V. Heller, Nuclear Cardiology Laboratory, Hartford Hospital, 80 Seymour Street, Hartford, Connecticut 06102. (Email: gheller{at}harthosp.org).

OBJECTIVES: The purpose of this research was to evaluate the significance of heart rate response to dobutamine and the assessment of left ventricular (LV) function during risk stratification of patients undergoing dobutamine stress myocardial perfusion imaging (DSMPI).

BACKGROUND: Dobutamine stress myocardial perfusion imaging has been shown to effectively risk stratify highly selected patients. However, based on perfusion alone, patients with normal and abnormal tests have twice the risk as comparable patients with exercise testing. The added value of assessment of LV function and the heart rate response to dobutamine in risk stratification of these patients is unknown.

METHODS: Follow-up information (cardiac death or non-fatal myocardial infarction) was obtained on 1,367 consecutive patients who underwent DSMPI due to inability to perform adequate exercise and contraindications to vasodilators. Perfusion images were interpreted using a 17-segment model. Abnormal perfusion and function were defined as: summed stress score ≥4 and ejection fraction <50%, respectively.

RESULTS: Annualized event rates (AERs) were related to the extent/severity of perfusion defects and worsening LV function. A three-risk category model was constructed from combined assessment of perfusion and function, with AERs of 2.4% (both normal), 5.8% (discordant), and 11.3% (both abnormal); p < 0.001. Stress electrocardiogram (ECG) data added incremental value to myocardial perfusion alone but not to combined assessment of perfusion and function. Importantly, inability to achieve 85% of mean predicted heart rate was associated with worse outcomes and was an independent predictor of cardiac events. For patients in whom perfusion, function, and stress ECG response were normal, inability to achieve target heart rate was associated with significantly higher AER (1.5% vs. 3.4%, respectively, p = 0.021).

CONCLUSIONS: In highly selected patients undergoing DSMPI, assessment of perfusion and function is effective in risk stratification. The stress ECG and heart rate response to dobutamine have prognostic value and should be incorporated into image interpretation so as to maximize risk stratification.

Abbreviations and Acronyms
  CAD = coronary artery disease
  CHF = congestive heart failure
  DSMPI = dobutamine stress myocardial perfusion imaging
  ECG = electrocardiographic/electrocardiogram
  LV = left ventricle or left ventricular
  LVEF = left ventricular ejection fraction
  MPHR = maximum predicted heart rate
  MPI = myocardial perfusion imaging
  SDS = summed difference score
  SPECT = single-photon emission computed tomography
  SRS = summed rest score
  SSS = summed stress score
  THR = target heart rate




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2324 - 2339.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Elhendy, A. F. Schinkel, J. J. Bax, and D. Poldermans
Risk Stratification With Electrocardiographic-Gated Dobutamine Stress Imaging
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1472 - 1472.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. M. Navare, J. F. Mather, and G. V. Heller
Reply
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1472 - 1473.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement